189 related articles for article (PubMed ID: 22129821)
1. Anticoagulant and Fibrinolytic Disorders in Patients with Behçet's Disease and Recurrent Aphthous Ulcer.
Shang H; Ye JJ; Ji M; Wang FF; Zhu YY; Qi XM
Chin J Physiol; 2011 Aug; 54(4):235-40. PubMed ID: 22129821
[TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behçet's disease.
Sun A; Chang JG; Kao CL; Liu BY; Wang JT; Chu CT; Yuan JH; Chiang CP
J Oral Pathol Med; 1996 May; 25(5):212-8. PubMed ID: 8835817
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms.
Rhee SH; Kim YB; Lee ES
J Korean Med Sci; 2005 Dec; 20(6):971-6. PubMed ID: 16361807
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for an association of Epstein-Barr virus with pre-ulcerative oral lesions in patients with recurrent aphthous ulcers or Behçet's disease.
Sun A; Chang JG; Chu CT; Liu BY; Yuan JH; Chiang CP
J Oral Pathol Med; 1998 Apr; 27(4):168-75. PubMed ID: 9563572
[TBL] [Abstract][Full Text] [Related]
5. Direct immunofluorescence in recurrent aphthous ulcers and Behçet's disease.
Reimer G; Luckner L; Hornstein OP
Dermatologica; 1983; 167(6):293-8. PubMed ID: 6363150
[TBL] [Abstract][Full Text] [Related]
6. HLA-A, B (Class I) and HLA-DR, DQ (Class II) antigens in Turkish patients with recurrent aphthous ulceration and Behçet's disease.
Pekiner FN; Aytugar E; Demirel GY; Borahan MO
Med Princ Pract; 2013; 22(5):464-8. PubMed ID: 23485763
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.
Pekiner FN; Aytugar E; Demirel GY; Borahan MO
J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease.
Lee JH; Jung JY; Bang D
J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111
[TBL] [Abstract][Full Text] [Related]
9. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S
Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994
[TBL] [Abstract][Full Text] [Related]
10. A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis.
Mumcu G; Sur H; Inanc N; Karacayli U; Cimilli H; Sisman N; Ergun T; Direskeneli H
J Oral Pathol Med; 2009 Nov; 38(10):785-91. PubMed ID: 19614861
[TBL] [Abstract][Full Text] [Related]
11. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.
Arabaci T; Kara C; Ciçek Y
J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
[TBL] [Abstract][Full Text] [Related]
13. Increased density of lymphocytes bearing gamma/delta T-cell receptors in recurrent aphthous ulceration (RAU).
Natah SS; Häyrinen-Immonen R; Hietanen J; Patinen P; Malmström M; Savilahti E; Konttinen YT
Int J Oral Maxillofac Surg; 2000 Oct; 29(5):375-80. PubMed ID: 11071244
[TBL] [Abstract][Full Text] [Related]
14. The significance of serum nitric oxide levels in Behçet's disease and recurrent aphthous stomatitis.
Yildirim M; Baysal V; Inaloz HS; Doguc D
J Dermatol; 2004 Dec; 31(12):983-8. PubMed ID: 15801262
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD.
Dalghous AM; Freysdottir J; Fortune F
Scand J Rheumatol; 2006; 35(6):472-5. PubMed ID: 17343257
[TBL] [Abstract][Full Text] [Related]
16. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
17. Increased beta 2 defensin in recurrent aphthous ulcer.
Al-Samadi A; Salem A; Ainola M; Hietanen J; Häyrinen-Immonen R; Konttinen YT
Oral Dis; 2015 Apr; 21(3):292-8. PubMed ID: 24854020
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Behcet's syndrome in patients with recurrent aphthous ulcerations in Brazil.
Tunes RS; Anjos TC; Martins GB; Barreto ER; Santiago MB
Rheumatol Int; 2009 Jun; 29(8):875-8. PubMed ID: 19037605
[TBL] [Abstract][Full Text] [Related]
19. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
[TBL] [Abstract][Full Text] [Related]
20. Possibility of a viral etiology in recurrent aphthous ulcers and Behçet's syndrome.
Hooks JJ
J Oral Pathol; 1978; 7(6):353-64. PubMed ID: 105094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
